Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week
... of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (MS) and to induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythamatosus. Acthar is not ...Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
... associated with increased levels of plasma cGMP, a secondary messenger of the target receptor, preserved renal function, increased natriuresis and diuresis with no effect on mean arterial pressure. About Heart Failure Heart failure is a chronic condition in which the heart cannot effectively pump ...Warning for women who binge drink
... the pain. After further investigation, bladder rupture was confirmed and all women underwent surgery to repair the bladder. In all these cases, diuresis (increased discharge of urine) and the dulling effect of alcohol, without the relief of bladder voiding, was thought to be the cause. Alcohol ...PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
... assessment of the potential benefits of induced diuresis with matched hydration therapy, compared to ... The CIN-prevention therapy of induced diuresis and matched hydration therapy will be provided ... is to assess the potential benefits of induced diuresis with matched hydration therapy compared to ...PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009
... is designed to provide an assessment of the potential benefits of induced diuresis with matched hydration therapy compared to standard overnight hydration, a ... impairment in renal function. The CIN-prevention therapy of induced diuresis and matched hydration therapy will be provided using RenalGuard. PLC ...RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009
... involving RenalGuard in the United States, was designed to test the safety of the RenalGuard System(TM) when used to provide high volume matched diuresis in patients at high risk for Contrast-Induced Nephropathy (CIN) undergoing angiography. A total of 23 patients were enrolled in the study, which was ...Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
... pre-clinical findings, including that CD-NP was associated with increased levels of plasma cGMP, preserved renal function, increased natriuresis and diuresis with minimal effect on mean arterial pressure. In parallel with Mayo's Phase Ib study, Nile is currently dosing Phase Ib and Phase IIa studies of ...Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
... pre-clinical findings, including that CD-NP was associated with increased levels of plasma cGMP, preserved renal function, increased natriuresis and diuresis with minimal effect on mean arterial pressure. In parallel with the Phase IIa study, Nile is completing its Phase Ib study of CD-NP. The primary ...Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
... pre-clinical findings, including that CD-NP activated its target receptor in humans, preserved renal function and caused increases in natriuresis and diuresis at doses associated with a minimal effect on mean arterial pressure. Nile believes that CD-NP could provide a valuable new treatment option for heart ...Nile Therapeutics, Inc. Adds to Executive Management Team
... pre-clinical findings, including that CD-NP activated its target receptor in humans, preserved renal function and caused increases in natriuresis and diuresis at doses associated with a minimal effect on mean arterial pressure. Nile believes that CD-NP could provide a valuable new treatment option for heart ...